Dr. Michael Wilczek is Assistant Teaching Professor in Biotechnology/Bioinformatics at Northeastern University's Roux Institute. His research bridges virology, bioinformatics, and educational innovation, with particular focus on JC polyomavirus pathogenesis and graduate education reform. Key research domains include: Molecular mechanisms of viral infections Bioinformatic analysis of host-pathogen interactions Observational health and real-world evidence Evidence-based graduate education His publication record demonstrates: Expertise in JC polyomavirus cellular pathways Innovative applications of machine learning in virology High-throughput drug screening methodologies Health disparities research in aging populations
Karl Griswold is a Professor of Engineering at Dartmouth College's Thayer School of Engineering, where he leads the Griswold Research Group focused on protein engineering and biotherapeutics development. His interdisciplinary work spans chemical, biological, and engineering disciplines to address critical challenges in drug-resistant infections and protein therapeutics. Education: BS in Chemistry from Southwest Texas State University (1995) PhD in Chemistry from the University of Texas at Austin (2005) Research Focus: Professor Griswold's laboratory specializes in protein engineering, directed evolution, and biotherapeutics development , creating novel biomolecules with superior functionality compared to natural proteins. The group develops high-throughput screening methods, protein deimmunization strategies, enhanced expression systems, and antibacterial agents targeting drug-resistant infections. Their work has significant translational potential for treating conditions like MRSA and Pseudomonas aeruginosa infections. Scientific Recognition: Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering (2008) NIH Biotechnology Training Grant (2000-2003) Royston M. Roberts - Regents Fellowship, University of Texas (1999) DOW Chemical Foundation Scholar, Texas State University (1991-1995) Senior Fellow, National Academy of Inventors Research Leadership: As co-founder and CEO of Stealth Biologics, Professor Griswold translates academic research into commercial applications. His work has secured NIH funding and Dartmouth Innovations Accelerator support, with research featured in Chemical & Engineering News, Vermont Public Radio, and the New Hampshire Union Leader for developing alternatives to traditional antibiotics. Research Environment: The Griswold Research Group maintains extensive collaborations across disciplines including clinical medicine, immunology, structural biology, and chemical engineering. This interdisciplinary approach prepares trainees for careers at the intersection of multiple scientific fields, with research focusing on Biomolecular Antimicrobial Therapies, Deimmunizing Protein Therapeutics, and Gene Library Construction Technologies.
Kesen Ma is an Associate Professor and Undergraduate Advisor in Biology at the University of Waterloo, specializing in hyperthermophile physiology and enzymology. His research explores metabolic processes at extreme temperatures for biofuel production, with affiliations at the Centre for Bioengineering and Biotechnology and Waterloo Centre for Microbial Research. His educational background includes: Ph.D. in Microbial Biochemistry from Philipps-Universität Marburg, Germany (1989) M.Sc. in Microbiology from Academia Sinica, Taiwan (1984) B.Sc. in Microbiology from Wuhan University, China (1982) Dr. Ma's research spans Microbiology , Biochemistry , and Renewable Energy , focusing on protein thermostability, novel metabolic pathways in extremophiles, and industrial applications of thermostable enzymes. His work bridges fundamental enzymology with practical biocatalysis for pharmaceutical and biofuel industries. Analysis of his 2017-2024 publications reveals consistent focus on alcohol dehydrogenases and pyruvate decarboxylases from thermophiles, emphasizing enzyme characterization, thermostability mechanisms, and high-temperature fermentation systems for ethanol production. His scientific recognition includes: Research Fellow at Max-Planck Institute, Philipps-Universität Marburg (1985) Graduate Scholarship from Academia Sinica, Beijing (1982) As Undergraduate Advisor for Biology, Dr. Ma mentors students while leading patented research on thermostable biocatalysts (US patent 8476051). His work has direct industrial applications in bioethanol production and stereo-specific compound synthesis. He actively collaborates through the Waterloo Centre for Microbial Research, focusing on extremophile enzymology for sustainable bioprocessing solutions.
Lucas Paoli is a Researcher and Course Instructor at École Polytechnique Fédérale de Lausanne (EPFL), Switzerland. He leads the Paoli Lab (Microbiome Immunity and Ecology) within the Global Health Institute (GHI) under the School of Life Sciences (SV). His roles include scientific collaboration and teaching responsibilities in life sciences engineering. Paoli holds a PhD in Microbiome Research from ETH Zürich (2018-2023), an M.Phil. in Environmental Policy from the University of Cambridge (2017-2018), and an M.Sc. in Ecology and Evolution from École normale supérieure (2015-2017). Research Focus: His work bridges microbial immunity and ecology, investigating how microbes defend against viral infections across ecosystems like oceans and human microbiomes. Techniques include global-scale metagenomics and functional genomics to study immune strategies and ecological interactions. Key themes involve microbial community dynamics, viral defense mechanisms, and the impact of environmental factors on microbial immunity. Lab & Education: The Paoli Lab explores microbiome-immunity interactions with a focus on ecological contexts. Paoli supervises PhD students in Life Sciences Engineering. His research outputs span microbial ecology, metagenomic tool development, and marine microbiome studies. Contact: lucas.paoli@epfl.ch, AAB 1 39, +41 21 693 16 99.
Lawrence Goodridge is a Professor and Director of the Canadian Research Institute for Food Safety (CRIFS) at the University of Guelph's Ontario Agricultural College. He holds the Leung Family Professorship in Food Safety and leads research at the intersection of food safety, antibiotic resistance, and One Health principles. His work focuses on applying genomic technologies to study foodborne pathogens (E. coli, Salmonella, Listeria, Cronobacter) and leveraging wastewater surveillance for infectious disease outbreak prediction. Academic History: BSc Microbiology (University of Guelph, 1995), MSc Food Microbiology (2003), PhD Food Microbiology (2002), followed by post-doctoral training in Food Safety at the University of Georgia (2002). Joined CRIFS in 2003. Research Interests: Genomic analysis of pathogen emergence, wastewater-based epidemiology, bacteriophage applications, and consumer education strategies for food safety. His lab develops innovative methods for rapid pathogen detection in food systems and environmental samples. Articles Trends: Over 100 peer-reviewed publications emphasize genomic surveillance of foodborne pathogens and SARS-CoV-2, with a focus on wastewater sampling innovations. Recent work explores multi-modal data integration for public health forecasting and ethical data protection frameworks for surveillance programs. Awards: While no specific prizes are listed, his $50M+ research funding from Canadian/international sources underscores recognition of his impactful work. Grants support projects like phage-based sanitization and antimicrobial resistance tracking. Advising & Labs: Leads CRIFS laboratory operations and collaborates globally on food safety initiatives. His research has informed food industry guidelines and policy frameworks for mitigating pathogen risks in agricultural and environmental systems.
Josh Atkinson is an Assistant Professor in the Department of Civil and Environmental Engineering and the Omenn-Darling Bioengineering Institute at Princeton University. His research focuses on using synthetic biology and protein engineering to control electron transport in microbes for environmental applications, such as bioelectronic sensors and bioremediation. The Atkinson Lab investigates microbial energy processing, biofilm-electronic interfaces, and sustainable biotechnologies. Affiliations: Princeton University, Omenn-Darling Bioengineering Institute Research Interests: Microbial electron transport, bioelectronic systems, environmental monitoring, sustainable catalysis His work bridges disciplines like electrochemistry, bioengineering, and environmental science to engineer living materials for real-world challenges. The lab recruits students across levels, emphasizing diversity and interdisciplinary collaboration. Recent projects include real-time contaminant sensors and light-controlled biofilm patterning. Articles highlight innovations in bioelectronics and microbial systems engineering. The lab’s future directions involve scaling-up bioelectronic devices and enhancing microbial community understanding.
Lars Engstrand is a Professor in infection control at Karolinska Institutet, heading the Translational Microbiome Research and Pandemic Preparedness group within the Department of Microbiology, Tumor and Cell Biology. His research spans multiple disciplines with a focus on translational microbiome research and pandemic preparedness. Engstrand's research interests center on understanding the human microbiome's role in health and disease, particularly in women's reproductive health and gastroenterology. His group has established multiple large-scale clinical studies including SweMaMi (Swedish Maternal Microbiome project), BASIC (associations between microbiota and preterm birth), VaMiGyn (Vaginal Microbiota in Gynaecological health), and several others investigating the vaginal microbiome's relationship to pregnancy outcomes, HPV infection, and cervical cancer. His team also conducts significant research on gut microbiome in inflammatory bowel disease and colorectal conditions through projects like PopCol and KOLBIBAKT. Analysis of Engstrand's most recent publications reveals a strong focus on the relationship between microbiome composition and women's health outcomes. His research consistently examines how vaginal, gut, and oral microbiomes influence pregnancy complications, preterm birth, HPV infection, and mental health during pregnancy. The work often employs large cohort studies with comprehensive sampling strategies across multiple body sites and time points, providing robust data for understanding microbiome dynamics in health and disease. Engstrand leads the Microbiome Exploration and Development for Intervention (MEDI) initiative and the National Pandemic Center (NPC) at Karolinska Institutet. The NPC conducted large-scale sequencing during the COVID-19 pandemic and has amassed over 1.5 million samples. His research group includes multiple specialized teams focusing on culturomics, bioinformatics, labcore operations, women's health research, and pandemic preparedness.
Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .
Dr. Igor V. Pivkin is a Full Professor at the Institute of Computing within the Faculty of Informatics at the Università della Svizzera italiana (USI) in Lugano, Switzerland. His academic journey includes degrees from Novosibirsk State University (B.Sc./M.Sc. Mathematics), Brown University (M.Sc. Computer Science and Ph.D. Applied Mathematics), and postdoctoral research at MIT's Department of Materials Science and Engineering. His research focuses on multiscale/multiphysics modeling , numerical methods , and large-scale simulations of biological and physical systems. Key areas include biophysics, cellular/molecular biomechanics, stochastic modeling, and coarse-grained molecular simulations. He leverages high-performance computing (HPC) and particle-based methods to address complex biological phenomena. His work spans diverse applications, from understanding cellular mechanosensitivity and biofilm engineering to modeling cancer cell behavior and red blood cell dynamics in the spleen. His contributions bridge computational science, biotechnology, and biomedical research. He has published extensively in top-tier journals, with recent work advancing automated biofilm analysis, deep learning for microbial classification, and systems biology approaches to metal bioleaching. His lab collaborates on interdisciplinary projects, emphasizing computational innovation for real-world biological challenges.
Jethro Johnson is an Innovation Track Principal Investigator at the Kennedy Institute of Rheumatology and Deputy Director of the Oxford Centre for Microbiome Studies (OCMS) at the University of Oxford. His work integrates computational genomics and microbiome research to explore host-microbiome interactions in health and disease. PhD in Nutritional Ecology (University of Auckland, 2012) MRC Career Development Fellowship Former postdoctoral researcher at Jackson Laboratory for Genomic Medicine Research focuses on: Mechanistic understanding of gut microbiome impacts on metabolic diseases Multi-omic data integration for host-microbiome studies Computational approaches to microbiome analysis Methodological developments in 16S rRNA gene profiling Publications emphasize microbiome-disease associations, methodological innovations, and computational genomics applications across human and mouse models. Key themes include metabolic dysfunction, immune interactions, and microbial diversity analysis. Scientific recognition includes: MRC Career Development Fellowship in Computational Genomics As OCMS Deputy Director, he contributes to advancing microbiome research infrastructure and collaborative projects while leading his own computational genomics group at the Kennedy Institute.
Simone Fior is a Lecturer at the Department of Environmental Systems Science , ETH Zürich , focusing on ecological genetics and plant adaptation. Their research integrates genomic, quantitative genetics, and ecological field experiments, particularly on Dianthus (Caryophyllaceae) along altitudinal and climatic gradients. Recent work explores climate-induced range shifts, local adaptation, and genomic responses to environmental changes. Professional experience includes roles at ETH Zürich since 2013 (Senior Assistant, Postdoc) and prior positions at the Edmund Mach Foundation (2009-2012) and University of Insubria (2007-2008). Education spans a PhD in Plant Biology (University of Milan, 2007) and an MSc in Natural Sciences (University of Milan, 2003). Simone co-organizes the Bioinformatics for Adaptation Genomics Winter School . Key research areas include adaptive divergence , polygenic adaptation , climate change biology , and phylogenomics . Articles emphasize genomic selection signatures, functional-structural modeling, and ecological-genetic interactions. Notable collaborations involve Jake Alexander, Alex Widmer, and interdisciplinary teams at ETH Zurich.
Juliane Nguyen, PhD, is a Professor in the Department of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. She serves as Vice Chair and Director of Graduate Admissions in her department and holds an adjunct appointment as Professor of Biomedical Engineering. Dr. Nguyen is also a member of the UNC Lineberger Comprehensive Cancer Center, where she applies molecular engineering approaches to develop innovative therapeutic solutions. Dr. Nguyen's research focuses on molecular engineering to advance protein-based therapeutics, live biotherapeutics (including engineered probiotic yeast), and extracellular vesicles. Her lab develops cutting-edge technologies to treat diverse conditions including cancer, myocardial infarction, chemotherapy-induced cardiotoxicity, and inflammatory bowel diseases. Her interdisciplinary approach integrates molecular engineering, pharmaceutical sciences, and bioinformatics to create complex biologics with exceptional safety and efficacy profiles. Key research areas include developing therapeutics for cardiac repair, genetically encoded materials targeting tumor-associated macrophages, live biotherapeutics for inflammatory bowel diseases using engineered probiotic yeast, and auxetic patches for dynamic organ repair. Analysis of Dr. Nguyen's recent publications reveals a strong focus on translational research with significant contributions to cardiac repair technologies, cancer immunotherapy, inflammatory bowel disease treatments, and advanced biomaterials. Her work consistently bridges fundamental molecular engineering with clinical applications, particularly in the areas of targeted drug delivery, extracellular vesicle therapeutics, and engineered live biotherapeutics. The research demonstrates a clear trajectory toward developing clinically viable solutions for previously challenging medical conditions. Dr. Nguyen has received numerous prestigious awards and honors including the NSF CAREER Award (2018), Eshelman Innovation Award (2020), and recognition as a Fellow of the Controlled Release Society (2023). She was appointed as a Standing Member of the NIH Drug and Biologic Therapeutic Delivery Study Section (2023-2025) and serves as Executive Editor of Advanced Drug Delivery Reviews since 2021. Her Galenus Guest Professorship at ETH Zuerich (2024) and keynotes at major conferences highlight her international recognition in the field. As Director of Graduate Admissions and an active mentor, Dr. Nguyen has advised numerous PhD and Master's students who have co-authored significant publications with her. Her research is supported by competitive grants including the NSF CAREER Award and other NIH-funded projects. The Nguyen Lab maintains strong collaborations across disciplines, particularly with cardiology, oncology, and biomedical engineering researchers. She leads an interdisciplinary team focused on translating molecular engineering breakthroughs into clinically impactful therapies. The Nguyen Lab operates as a dynamic, interdisciplinary research environment combining expertise in molecular engineering, pharmaceutical sciences, and bioinformatics. The lab's mission is to revolutionize medicine by developing next-generation therapeutics that target diseases at the molecular level. Current projects focus on translating cutting-edge research into life-changing therapies for patients suffering from cancer, myocardial infarction, colitis, and other challenging conditions. The lab's innovative approach to biomolecular engineering positions it at the forefront of developing safe, effective, and personalized therapeutic solutions.
Samarpita Roy is an Assistant Professor at TU Delft's Faculty of Applied Sciences, leading the Environmental Biotechnology department's Samarpita Roy Group. Her research focuses on microbial ecology in engineered bioprocesses, integrating metagenomics and quantitative physiology to study microbial metabolisms and community interactions. Key projects include exploring phototrophic and polyphosphate-accumulating organisms in wastewater treatment for nutrient/resource recovery. She actively seeks industrial collaborations and is hiring PhD candidates in metagenomics/microbial ecology. Research emphasizes understanding microbial community dynamics under fluctuating conditions, developing sequencing/data analysis workflows, and applying findings to enhance bioprocess efficiency. Her work aims to advance circular bioeconomy solutions through innovative biotechnology approaches.
Eduardo Rocha is a Professor and Head of the Microbial Evolutionary Genomics laboratory at the Institut Pasteur, within the Department of Genomes and Genetics. His research integrates bioinformatics, molecular evolution, and genomics to understand bacterial genome organization and dynamics, particularly focusing on mobile genetic elements and their role in adaptation and antibiotic resistance. His research interests include microbial evolutionary genomics, genome organization, horizontal gene transfer, mobile genetic elements (plasmids, phages, integrons), bacterial pathogen evolution, and computational biology. His work lies at the intersection of molecular evolution, population genetics, and molecular epidemiology, with strong translational implications for understanding antimicrobial resistance and infectious disease emergence. The recent publications highlight a consistent focus on mobile genetic elements, genome plasticity, and bacterial adaptation. Key themes include the role of integrons and CRISPR-Cas systems in bacterial immunity, plasmid-mediated spread of antibiotic resistance, phage-plasmid interactions, and the development of bioinformatics tools for microbial genomics. These works frequently appear in high-impact journals such as Science , Nature Microbiology , and PLoS Biology , reflecting significant contributions to the field. Eduardo Rocha leads multiple funded research projects, including ERC-2011-StG EVOMOBILOME, ANR Magisbac, and ANR SHAPE. He has developed and maintains several widely used bioinformatics software tools: IntegronFinder, MacSyFinder, PanACoTA, SatelliteFinder, CapsuleFinder, TXSScan, and others. He mentors a large team of PhD students, postdoctoral researchers, and engineers, and has supervised numerous former students who now hold independent research positions worldwide. Eduardo Rocha has received research funding from major agencies including the European Research Council (ERC) and the French National Research Agency (ANR). His work is central to the LabEx IBEID and the INCEPTION convergence program, where he serves on the steering committee, promoting interdisciplinary research in infectious disease emergence. His laboratory, part of the Genomes and Genetics department, actively contributes to microbial evolutionary genomics through both methodological development and biological discovery. The team participates in networks such as Phages.fr, GDR BIM, and GDR AIEM, reinforcing its collaborative and integrative approach.
Ian Bradley is an Assistant Professor in the Department of Civil, Structural and Environmental Engineering at the University at Buffalo, State University of New York. His research focuses on creating sustainable biological processes to address needs in engineered and natural systems for water and wastewater treatment and resource recovery. Education: PhD in Environmental Engineering, University of Illinois at Urbana-Champaign (2017) MS in Environmental Engineering, University of Illinois at Urbana-Champaign (2011) MS in Civil Engineering (Structures), University of Illinois at Urbana-Champaign (2010) Research Interests: Dr. Bradley specializes in microalgal-based nutrient recovery, wastewater surveillance for public health monitoring, PFAS degradation using nanomaterials, and sustainable resource recovery systems. His work integrates biological processes with environmental engineering to optimize wastewater treatment efficiency and develop predictive models for water quality and health outcomes. Publications: His recent research includes advancements in microalgal cultivation (EcoRecover process), wastewater-based epidemiology for SARS-CoV-2 tracking, and computational enzyme design for PFAS remediation. These studies demonstrate interdisciplinary expertise spanning environmental engineering, biotechnology, and public health analytics.
